Epidermal Growth Factor (EGF) (Middle Region) Peptide
-
- Target See all EGF products
- EGF (Epidermal Growth Factor (EGF))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EGF antibody (Catalog #: ARP41486_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EGF (Epidermal Growth Factor (EGF))
- Background
-
Epidermal growth factor has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells of both ectodermal and mesodermal origin. The EGF precursor is believed to exist as a membrane-
Alias Symbols: URG, HOMG4
Protein Interaction Partner: EGFR,EGFR,EGFR,ADAM12,ADRBK1,CPM,DUSP3,EGF,EGFR,ERBB2,ERBB3,GRB2,LMNA,NRG1,PIK3R2,VTN,EGF,EGFR,ERBB2,ERBB3,FNBP1,MAPKAPK2,PIK3R2,RPS6KA5,VTN
Protein Size: 1207 - Molecular Weight
- 6 kDa
- Gene ID
- 1950
- NCBI Accession
- NM_001963, NP_001954
- UniProt
- P01133
-